| 1 |
Armoni, M., Kritz, N., Harel, C., Bar-Yoseph, F., Chen, H., Quon, M. J. and Karnieli, E. 2003. Peroxisome proliferator- activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. J Biol Chem 278, 30614-30623.
DOI
ScienceOn
|
| 2 |
Barnea, M., Shamay, A., Stark, A. H. and Madar, Z. 2006. A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression. Obesity (Silver Spring) 14, 2145-2153.
DOI
|
| 3 |
Bays, H. E. 2009. "Sick fat," metabolic disease, and atherosclerosis. Am J Med 122, S26-37.
DOI
ScienceOn
|
| 4 |
Berg, A. H., Combs, T. P. and Scherer, P. E. 2002. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13, 84-89.
DOI
ScienceOn
|
| 5 |
Bullen, J. W. Jr., Bluher, S., Kelesidis, T. and Mantzoros, C. S. 2007. Regulation of adiponectin and its receptors in response to development of diet-induced obesity in mice. Am J Physiol Endocrinol Metab 292, E1079-1086.
DOI
|
| 6 |
Ceddia, R. B., Somwar, R., Maida, A., Fang, X., Bikopoulos, G. and Sweeney, G. 2005. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 48, 132-139.
DOI
ScienceOn
|
| 7 |
Fruebis, J., Tsao, T. S., Javorschi, S., Ebbets-Reed, D., Erickson, M. R., Yen, F. T., Bihain, B. E. and Lodish, H. F. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98, 2005-2010.
DOI
ScienceOn
|
| 8 |
Fu, Y., Luo, N., Klein, R. L. and Garvey, W. T. 2005. Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res 46, 1369-1379.
DOI
ScienceOn
|
| 9 |
Havel, P. J. 2002. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13, 51-59.
DOI
ScienceOn
|
| 10 |
Higuchi, A., Ohashi, K., Shibata, R., Sono-Romanelli, S., Walsh, K. and Ouchi, N. 2010. Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism. Arterioscler Thromb Vasc Biol 30, 46-53.
DOI
ScienceOn
|
| 11 |
Kim, J., Jeong, J. I., Kim, K. M., Choi, I., Pratley, R. E. and Lee, Y. H. 2014. Improved glucose tolerance with restored expression of glucose transporter 4 in C57BL/6 mice after a long period of high-fat diet feeding. Animal Cells Syst(Seoul) 18, 197-203.
과학기술학회마을
DOI
ScienceOn
|
| 12 |
Jensterle, M., Janez, A., Mlinar, B., Marc, J., Prezelj, J. and Pfeifer, M. 2008. Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome. Eur J Endocrinol 158, 793-801.
DOI
ScienceOn
|
| 13 |
Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K., Ueki, K. and Tobe, K. 2006. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116, 1784-1792.
DOI
ScienceOn
|
| 14 |
Kahn, B. B. 1992. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 89, 1367-1374.
DOI
|
| 15 |
Lee, Y. H. and Pratley, R. E. 2007. Abdominal obesity and cardiovascular disease risk: the emerging role of the adipocyte. J Cardiopulm Rehabil Prev 27, 2-10.
DOI
|
| 16 |
Lee, Y. H. and Pratley, R. E. 2005. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 5, 70-75.
DOI
ScienceOn
|
| 17 |
Lee, Y. H., Tharp, W. G., Maple, R. L., Nair, S., Permana, P. A. and Pratley, R. E. 2008. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring) 16, 1493-1500.
DOI
ScienceOn
|
| 18 |
Minokoshi, Y., Kahn, C. R. and Kahn, B. B. 2003. Tissue-specific ablation of the GLUT4 glucose transporter or the insulin receptor challenges assumptions about insulin action and glucose homeostasis. J Biol Chem 278, 33609-33612.
DOI
ScienceOn
|
| 19 |
Mantzoros, C. S., Li, T., Manson, J. E., Meigs, J. B. and Hu, F. B. 2005. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab 90, 4542-4548.
DOI
|
| 20 |
Marecki, J. C., Ronis, M. J., Shankar, K. and Badger, T. M. 2011. Hyperinsulinemia and ectopic fat deposition can develop in the face of hyperadiponectinemia in young obese rats. J Nutr Biochem 22, 142-152.
DOI
ScienceOn
|
| 21 |
Martinez, L., Berenguer, M., Bruce, M. C., Le Marchand- Brustel, Y. and Govers, R. 2010. Rosiglitazone increases cell surface GLUT4 levels in 3T3-L1 adipocytes through an enhancement of endosomal recycling. Biochem Pharmacol 79, 1300-1309.
DOI
ScienceOn
|
| 22 |
Ouchi, N., Parker, J. L., Lugus, J. J. and Walsh, K. 2011. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11, 85-97.
DOI
ScienceOn
|
| 23 |
Park, S. Y., Choi, G. H., Choi, H. I., Ryu, J., Jung, C. Y. and Lee, W. 2005. Calorie restriction improves whole-body glucose disposal and insulin resistance in association with the increased adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima fatty rats. Arch Biochem Biophys 436, 276-284.
DOI
ScienceOn
|
| 24 |
Pi-Sunyer, F. X. 2002. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 10 Suppl 2, 97S-104S.
DOI
|
| 25 |
Rajala, M. W. and Scherer, P. E. 2003. Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773.
DOI
ScienceOn
|
| 26 |
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. and Lodish, H. F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270, 26746-26749.
DOI
ScienceOn
|
| 27 |
Vozarova, B., Stefan, N., Lindsay, R. S., Krakoff, J., Knowler, W. C., Funahashi, T., Matsuzawa, Y., Stumvoll, M., Weyer, C. and Tataranni, P. A. 2002. Low plasma adiponectin concentrations do not predict weight gain in humans. Diabetes 51, 2964-2967.
DOI
ScienceOn
|
| 28 |
Shimada, K., Miyazaki, T. and Daida, H. 2004. Adiponectin and atherosclerotic disease. Clin Chim Acta 344, 1-12.
DOI
ScienceOn
|
| 29 |
Staels, B. and Fruchart, J. C. 2005. Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54, 2460-2470.
DOI
ScienceOn
|
| 30 |
Tomas, E., Tsao, T. S., Saha, A. K., Murrey, H. E., Zhang Cc, C., Itani, S. I., Lodish, H. F. and Ruderman, N. B. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99, 16309-16313.
DOI
ScienceOn
|
| 31 |
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E. and Tataranni, P. A. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86, 1930-1935.
DOI
|
| 32 |
Winzer, C., Wagner, O., Festa, A., Schneider, B., Roden, M., Bancher-Todesca, D., Pacini, G., Funahashi, T. and Kautzky- Willer, A. 2004. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27, 1721-1727.
DOI
ScienceOn
|
| 33 |
Wu, X., Motoshima, H., Mahadev, K., Stalker, T. J., Scalia, R. and Goldstein, B. J. 2003. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355-1363.
DOI
ScienceOn
|
| 34 |
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama- Kasaoka, N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P. and Kadowaki, T. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7, 941-946.
DOI
ScienceOn
|
| 35 |
Ziemke, F. and Mantzoros, C. S. 2010. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91, 258S-261S.
DOI
ScienceOn
|
| 36 |
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., Komuro, R., Ouchi, N., Kihara, S., Tochino, Y., Okutomi, K., Horie, M., Takeda, S., Aoyama, T., Funahashi, T. and Matsuzawa, Y. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8, 731-737.
DOI
ScienceOn
|
| 37 |
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., Murakami, K., Ohteki, T., Uchida, S., Takekawa, S., Waki, H., Tsuno, N. H., Shibata, Y., Terauchi, Y., Froguel, P., Tobe, K., Koyasu, S., Taira, K., Kitamura, T., Shimizu, T., Nagai, R. and Kadowaki, T. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
DOI
ScienceOn
|
| 38 |
Estrany, M. E., Proenza, A. M., Gianotti, M. and Llado, I. 2013. High-fat diet feeding induces sex-dependent changes in inflammatory and insulin sensitivity profiles of rat adipose tissue. Cell Biochem Funct 31, 504-510.
DOI
ScienceOn
|
webmaster
